| Financial Year |
March 31 2023 |
| Monetary Funds |
46,540,898.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
950,000.00 |
| Accounts Receivable |
174,109,354.21 |
| Advances to Suppliers |
25,782,164.92 |
| Other Receivables |
114,642,263.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,609,335.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,315,131.27 |
| Other Current Assets |
3,284,400.41 |
| Total Current Assets |
506,928,798.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,314,190.66 |
| Long-term Equity Investment |
7,443,555.07 |
| Investment Properties |
538,243.64 |
| Fixed Assetes |
830,981,780.37 |
| Under-construction Projects |
15,657,320.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,734,610.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,244.00 |
| Deferred Income Tax Assets |
100,838,838.02 |
| Other Non-Current Assets |
97,355,393.46 |
| Sub-Total of Non-Current Assets |
1,100,426,089.11 |
| Total Assets |
1,607,354,887.22 |
| Short-Term Loans |
109,224,099.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,171,484.71 |
| Accounts Payable |
554,419,858.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,037,370.37 |
| Taxes Payable |
2,337,667.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
312,917,566.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
335,324.61 |
| Other Current Liabilities |
12,107,663.20 |
| Sub-Total of Current Liabilities |
1,176,948,116.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
72,543,431.00 |
| Deferred Income Tax Liabilities |
1,788,223.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
79,747,917.86 |
| Total Liabilities |
1,256,696,034.23 |
| Paid-In Capital(Or Share Stock) |
373,936,278.00 |
| Capital Surplus |
1,908,352,096.22 |
| Surplus Reserve |
49,021,098.56 |
| LESS:Treasury Stock |
101,550,000.00 |
| Undistributed Profits |
-1,882,041,004.46 |
| Minority Stockholder's Interest |
-87,806.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
350,746,659.28 |
| Owner's Equity（Stockholder's Equity） |
350,658,852.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,607,354,887.22 |
